Leonidas Capital S.A. (WSE : LEO) agreed to acquire 25.1% stake in Red Pharma Laboratories Polska Sp z o.o for PLN 0.15 million on September 7, 2016. Leonidas Capital S.A. (WSE : LEO) cancelled the acquisition of 25.1% stake in Red Pharma Laboratories Polska Sp z o.o on September 7, 2017.